Lipoprotein(a) & 2026 ACC/AHA Guideline on the Management of Dyslipidemia

This live webinar will feature guideline writing committee member Dr. Donald Lloyd-Jones, past American Heart Association President, & Dr. Frank Qian addressing key insights from the updated guideline: • Understand Lp(a) and Its Role in CVD: define its function and impact on ASCVD risk • Lipoprotein(a) measurement recommendation update and clinical considerations for elevated values • PREVENT-ASCVD equations and how they guide lipid lowering therapy • Lipid treatment goal overview